{"schema_version":"secwatch.filing_event.v1","accession":"0001420800-23-000021","form_type":"8-K","ticker":"ENOV","cik":"0001420800","company_name":"Enovis CORP","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.875220+00:00","generated_at":"2026-06-12T07:44:11.464394+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Enovis Q2 sales up 8% to $429M; raises full-year guidance on organic growth and margin expansion","bullets":["Q2 net sales $429M, +8% YoY; organic sales per day growth 9%.","Reconstructive segment grew 18% (17% organic); Prevention & Recovery grew 4%.","Net loss from continuing ops $0.27 per share; adjusted EPS $0.61.","Full-year 2023 guidance raised: organic revenue growth now 7-7.5% (prev 6-7%), adjusted EBITDA $262-270M.","Adjusted EBITDA margin improved 110bps to 15.3% of sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001420800-23-000021","json":"https://secwatch.observer/filing/0001420800-23-000021.json","markdown":"https://secwatch.observer/filing/0001420800-23-000021.md","text":"https://secwatch.observer/filing/0001420800-23-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420800/000142080023000021/0001420800-23-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420800/000142080023000021/cfx-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:44:11.464394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9c7b6476eeca7a27124b73219699c81c8feed572","claim":"Enovis CORP reported the second quarter ended June 30, 2023 results: revenue $429 million, EPS net loss from continuing operations of $0.27 per share. Guidance raised.","evidence_excerpt":"Enovis’ second quarter net sales of $429 million grew 8% from the same quarter a year ago, including 9% organic sales per day growth, and reflecting a 0.7% sales days headwind which was slightly offset by currency and recent acquisitions.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420800/000142080023000021/0001420800-23-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended June 30, 2023"},{"label":"Revenue","value":"$429 million"},{"label":"EPS","value":"net loss from continuing operations of $0.27 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}